VYNE Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $0.2M beats by $0.1M
Source: SeekingAlpha
2025-11-06 12:05:31 ET
More on VYNE Therapeutics
- Seeking Alpha’s Quant Rating on VYNE Therapeutics
- Historical earnings data for VYNE Therapeutics
- Financial information for VYNE Therapeutics
Read the full article on Seeking Alpha
For further details see:
VYNE Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $0.2M beats by $0.1M
VYNE Therapeutics Inc Com
NASDAQ: VYNE
VYNE Trading
-0.92% G/L:
$0.5933 Last:
153,493 Volume:
$0.59 Open:
VYNE Latest News
December 17, 2025 12:30:00 pm
VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders
VYNE Stock Data
$18,453,992
28,952,530
2.3%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Stewartsville
